SE8005498L - Homogent fibroblastinterferon och framstellning derav - Google Patents

Homogent fibroblastinterferon och framstellning derav

Info

Publication number
SE8005498L
SE8005498L SE8005498A SE8005498A SE8005498L SE 8005498 L SE8005498 L SE 8005498L SE 8005498 A SE8005498 A SE 8005498A SE 8005498 A SE8005498 A SE 8005498A SE 8005498 L SE8005498 L SE 8005498L
Authority
SE
Sweden
Prior art keywords
residues
amino acid
homogent
fibroblast
interference
Prior art date
Application number
SE8005498A
Other languages
Unknown language ( )
English (en)
Other versions
SE466290B (sv
Inventor
H-J Friesen
S Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8005498L publication Critical patent/SE8005498L/sv
Publication of SE466290B publication Critical patent/SE466290B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8005498A 1979-07-31 1980-07-31 Homogent humant fibroblastinterferon, dess framstaellning och farmaceutiska preparat paa basis daerav SE466290B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (2)

Publication Number Publication Date
SE8005498L true SE8005498L (sv) 1981-02-01
SE466290B SE466290B (sv) 1992-01-27

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8005498A SE466290B (sv) 1979-07-31 1980-07-31 Homogent humant fibroblastinterferon, dess framstaellning och farmaceutiska preparat paa basis daerav

Country Status (33)

Country Link
US (1) US5015730A (sv)
JP (1) JPH02138226A (sv)
AR (1) AR229931A1 (sv)
AT (1) AT372387B (sv)
AU (1) AU536274B2 (sv)
CA (1) CA1146468A (sv)
CH (1) CH648331A5 (sv)
DE (1) DE3028919A1 (sv)
DK (1) DK159825C (sv)
DO (1) DOP1980002948A (sv)
ES (1) ES493849A0 (sv)
FI (1) FI70721C (sv)
FR (1) FR2462167B1 (sv)
GB (1) GB2055384B (sv)
HK (1) HK40384A (sv)
HU (1) HU185382B (sv)
IE (1) IE50075B1 (sv)
IL (1) IL60697A (sv)
IT (1) IT1132269B (sv)
KE (1) KE3364A (sv)
LU (1) LU82673A1 (sv)
MC (1) MC1337A1 (sv)
MY (1) MY8500274A (sv)
NL (1) NL8004361A (sv)
NO (1) NO151158C (sv)
NZ (1) NZ194495A (sv)
PH (2) PH17738A (sv)
PT (1) PT71625B (sv)
RO (1) RO81474B (sv)
SE (1) SE466290B (sv)
YU (1) YU193480A (sv)
ZA (1) ZA803943B (sv)
ZW (1) ZW17980A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES500966A0 (es) 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
SG155183A1 (en) 2005-08-26 2009-09-30 Ares Trading Sa Process for the preparation of glycosylated interferon beta
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
JP2011500756A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Fc融合タンパク質を精製する方法
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
PH18479A (en) 1985-07-18
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
LU82673A1 (fr) 1982-02-17
FI70721C (fi) 1986-10-06
MY8500274A (en) 1985-12-31
AT372387B (de) 1983-09-26
IL60697A0 (en) 1980-09-16
DK159825B (da) 1990-12-10
MC1337A1 (fr) 1981-04-21
NO802297L (no) 1981-02-02
DK159825C (da) 1991-04-29
IL60697A (en) 1984-04-30
NZ194495A (en) 1984-07-31
IE50075B1 (en) 1986-02-05
AR229931A1 (es) 1984-01-31
US5015730A (en) 1991-05-14
JPH02138226A (ja) 1990-05-28
SE466290B (sv) 1992-01-27
RO81474B (ro) 1983-04-30
ZW17980A1 (en) 1981-03-18
FR2462167A1 (fr) 1981-02-13
ES8200560A1 (es) 1981-11-16
FI70721B (fi) 1986-06-26
IT8023801A0 (it) 1980-07-30
NO151158B (no) 1984-11-12
AU6091480A (en) 1981-02-05
NO151158C (no) 1985-02-20
DE3028919A1 (de) 1981-02-19
DOP1980002948A (es) 1989-04-20
PH17738A (en) 1984-11-23
DK328880A (da) 1981-02-01
ATA395080A (de) 1983-02-15
YU193480A (en) 1984-04-30
HK40384A (en) 1984-05-18
AU536274B2 (en) 1984-05-03
RO81474A (ro) 1983-04-29
CA1146468A (en) 1983-05-17
PT71625A (en) 1980-08-01
ES493849A0 (es) 1981-11-16
FR2462167B1 (fr) 1985-07-05
GB2055384B (en) 1983-08-10
CH648331A5 (de) 1985-03-15
KE3364A (en) 1984-02-03
HU185382B (en) 1985-01-28
IT1132269B (it) 1986-07-02
ZA803943B (en) 1981-06-24
GB2055384A (en) 1981-03-04
IE801589L (en) 1981-01-31
FI802400A (fi) 1981-02-01
DE3028919C2 (sv) 1988-02-18

Similar Documents

Publication Publication Date Title
SE8005498L (sv) Homogent fibroblastinterferon och framstellning derav
Yip et al. Partial purification and characterization of human gamma (immune) interferon.
BR1100044A (pt) Composições de eritropoietinas homogêneas
ES8103976A1 (es) Un metodo de producir proteinas de interferon humano de for-ma le
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
IE811463L (en) Interferons
Törmä et al. Purification and characterization of human leukocyte interferon components.
ATE37564T1 (de) Reinigung von interleukin-2.
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
HUT43188A (en) Monoclonic antibodies and antigenes for treatment of human, having not-small celts carcinoma of lungs
KR860008270A (ko) α-인터페론의 제조 및 정제 방법
塩見一雄 et al. Purification of a lethal factor in the skin secretion from the oriental catfish Plotosus lineatus.
Cachard et al. Enhancement of mouse interferon production by combined treatment of C-243 cells with butyric acid and theophylline
Duñach et al. The relationship between the chromophore moiety and the cation binding sites in bacteriorhodopsin
Chesterman et al. Comparison of platelet-derived growth factor prepared from release products of fresh platelets and from outdated platelet concentrates
ATE136552T1 (de) Reinigung von menschlichem, aus einer escherichia coli mutante abgesonderten interleukin 4
Rusenko et al. Interaction of [125 I] β nerve growth factor with acidic proteins
KR930004326A (ko) 콘드로모듈린-ii 단백질
EP0446850B1 (en) Process for purifying recombinant human beta-interferon
Dodd et al. Elution of interferon β from Blue Sepharose by poly (vinylpyrrolidone)
Khanaka et al. Comparative study of the DNA-binding HU-type proteins from slow growing and fast growing strains of Rhizobiaceae
Champagne et al. The Core Histones from the Slime Mold Physarum polycephalum: Isolation and Characterization
Knight Jr et al. [40] In vivo radiolabeling of human IFN-β
Jacobs et al. Molecular identification and characterization of a protein lymphokine exhibiting macrophage migration inhibition activity
Okude et al. Microheterogeneity of cross-linked γ dimers isolated from bovine stabilized fibrin

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8005498-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8005498-4

Format of ref document f/p: F